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a b s t r a c t
Ethnopharmacological relevance: Serotherapy against snakebite is often unavailable in some regions over
Brazil, where people make use of plants from folk medicine to deal with ophidic accidents. About 10% of
Combretum species have some ethnopharmacological use, including treatment of snakebites.
Materials and methods: We evaluated the ability of the extract of Combretum leprosum and its component
arjunolic acid to reduce some in vivo and in vitro effects of Bothrops jararacussu and Bothrops jararaca
venoms. The protocols investigated include phospholipase, proteolytic, collagenase, hyaluronidase,
procoagulant, hemorrhagic, edematogenic, myotoxic and lethal activities induced by these venoms in
Swiss mice.
Results: Oral pre-treatment with arjunolic acid reduced the Bothrops jararacussu lethality in up to 75%,
while preincubation prevented the death of all the animals. Hemoconcentration effect of Bothrops
jararacussu venom was conﬁrmed two hours after i.p. injection, while preincubation with arjunolic acid
preserved the hematocrit levels. Both Combretum leprosum extract and arjunolic acid abolished the
myotoxic action of Bothrops jararacussu venom. Preincubation of Bothrops jararacussu venom with
the extract or arjunolic acid prevented the increase of plasma creatine kinase activity in mice. The
hemorrhagic activity of Bothrops jararaca crude venom was reduced down to about 90% and completely
inhibited by preincubation with 10 mg/kg or 100 mg/kg Combretum leprosum extract, respectively, while
the preincubation and the pretreatment with 30 mg/kg of arjunolic acid reduced the venom hemorrhagic
activity down to about 12% and 58%, respectively. The preincubation of the venom with both extract and
30 mg/kg arjunolic acid signiﬁcantly reduced the bleeding amount induced by Bothrops jararacussu
venom. The extract of Combretum leprosum decreased the edema formation induced by Bothrops
jararacussu venom both in preincubation and pretreatment, but not in posttreatment. Similarly, arjunolic
acid preincubated with the venom abolished edema formation, while pre- and posttreatment have been
partially effective. Some enzymatic activities of Bothrops jararacussu and Bothrops jararaca venoms, i.e.
phospholipase A2, collagenase, proteolytic and hyaluronidase activities, were to some extent inhibited by
the extract and arjunolic acid in a concentration-dependent manner.
Conclusions: Altogether, our results show that Combretum leprosum extract can inhibit different activities
of two important Brazilian snake venoms, giving support for its popular use in folk medicine in the
management of venomous snakebites.
& 2014 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Medicinal plants have long been used in the treatment of
snakebite, mainly in locations where it is difﬁcult to obtain the
speciﬁc antivenom. In some countries, knowledge and access to
medicinal plant therapy is traditional, and such therapy can be
important for many reasons. One is the lack of speciﬁc antivenom,
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or because of the time needed to travel to a treatment location.
Sometimes, therapy with speciﬁc antivenom may be partly or
wholly ineffective (Mors et al., 1989, 2000a; Chippaux et al., 1991;
Da Silva et al., 2007). These natural sources in folk medicine are
important in many countries where snakebite treatment is a
public-health problem, and its treatment is a challenge for these
communities (Watt, 1989; Chippaux and Goyffon, 1997; Mors
et al., 2000b; Gutiérrez et al., 2013a).
Although many species of plants are popularly known to be
antiophidic agents, only a few have been investigated and had
their active components isolated or characterized (Melo et al.,
1994; Mors et al., 2000a; Coe and Anderson, 2005; Veronese et al.,
2005; Strauch et al., 2013). Plants are important sources of
bioactive components such as ﬂavonoids, coumestans and triter-
penes, which can help in the treatment of accidents with veno-
mous animals (Mors et al., 1989, 2000a). Generally, substances of
medical interest are found in very small quantities in the plants
and are affected by many factors such as season of the year, time of
collection, growth period, climate, soil composition, part of the
plant from which the active component is extracted, or the batch
collected (Havsteen, 1983; Mors et al., 2000a, 2000b).
In Brazil, the majority of accidents with venomous snakes are due
to Bothrops sp. envenomation, which causes mainly local tissue
damage, hemorrhage, edema and myonecrosis. Administration of
the speciﬁc antivenom may prevent death but does not prevent local
tissue damage and resultant disabilities (Da Silva et al., 2007).
Antiophidic plants have been a target of previous studies from our
group, such as Eclipta prostrata, which showed strong effects against
venoms of snakes of the genera Bothrops, Lachesis, and Crotalus or
some of their puriﬁed toxins, such as bothropstoxin, bothropasin, and
crotoxin (Mors et al., 1989; Melo et al., 1994). The crude extract, as
well as the isolated components wedelolactone, sitosterol, and
stigmasterol, have shown intense antimyotoxic, antihemorrhagic,
and antilethal activities against some snake venoms and isolated
toxins (Mors et al., 1989; Melo et al., 1994; Melo and Ownby, 1999).
Studies with Casearia sylvestris, Harpalyce brasiliana and Humir-
ianthera ampla have also demonstrated that these plants inhibited
the myotoxic, edematogenic, and anticoagulant activities of several
Bothrops venoms and isolated toxins (Borges et al., 2001; Da Silva
et al., 2004; Strauch et al., 2013).
We have noticed that the plants from Combretum genus have
been used as antivenom in folk medicine in Brazil and other regions
of the world, especially in Africa. This plant is a member of the family
Combretaceae, constituted by circa 600 species in 18 genera, of
which Teminalia and Combretum are the most important. Worldwide,
species of Combretum are popularly used against several diseases,
most of the times used as infusions or decoctions of the leafs, ﬂowers
or roots (Facundo et al., 1993, 2005; Agra, 1996; Mors et al., 2000b;
McGaw et al., 2001) including snakebites (Hutchings et al., 1996; Van
Wyk et al., 1997). Combretum leprosum is found in Northeast Brazil,
growing mainly along riverbanks, where it is called “mofumbo”,
“mufumbo” or “pente de macaco” (Pio Corrêa, 1984). The
phytochemical analysis of Combretum leprosum extract showed the
presence of monosaccharides as the major compounds (80%), fol-
lowed by triterpenes (10%) such as arjunolic acid (Fig. 1), and yet
oligosaccharides (5%) and fatty acids (3%) (Facundo et al., 1993, 2005).
In the present study, the Combretum leprosum extract and the
isolated triterpene arjunolic acid were investigated under different
experimental protocols in vivo and in vitro against some important
activities of Bothrops jararacussu and Bothrops jararaca venoms.
2. Material and methods
Bothrops jararaca and Bothrops jararacussu venoms and the
antibothropic polyvalent antivenom (PAV) were obtained from
Instituto Vital Brazil, Niterói, RJ. Bothropstoxin II was obtained
from Faculdade de Ciências Farmacêuticas/USP, Ribeirão Preto-SP.
Creatine kinase (CK) activity was determined using a CK NACs kit
from BIOCLINs. Azocaseins, azocolls, and hyaluronic acid were
purchased from Sigma Chemical Co., USA. Male Swiss mice were
provided by the Rodent Vivarium of the Institute of Microbiology
Paulo de Góes – Federal University of Rio de Janeiro. Mice
(25.071.0 g) used for the study received water and food ad libitum
and were kept under a natural light cycle. We adhered to protocols
approved by the Ethics Committee for the Use of Animals of the
Federal University of Rio de Janeiro (CEUA-UFRJ).
2.1. Plant material, extraction and isolation
Botanical material (Combretum leprosum) was collected in May
2001 in Viçosa, State of Ceará, Brazil. The material was identiﬁed at
the Prisco Bezerra herbarium of the Biology Department, Federal
University of Ceará, and a voucher specimen was deposited under
number 12446.
Ethanolic extract was obtained from the roots (2.7 kg), which
were placed in contact with ethanol 98% (5 L) at room temperature
for 72 h. The material was ﬁltered and the solvent evaporated
under reduced pressure, yielding 58.3 g of extract. The isolation of
arjunolic acid was performed as previously described (Facundo
et al., 1993). Part of the extract (34.0 g) was submitted to coarse
chromatography over silica gel using as eluents hexane, clorofor-
mium, ethyl acetate, and methanol. In the fraction eluted with
ethyl acetate the presence of a white precipitate was observed,
which, through recrystallization in methanol, was identiﬁed as
the triterpene arjunolic acid. Spectral data, mainly mass spectro-
metry, 1H and 13C NMR were in agreement with literature values
(Facundo et al., 1993).
2.2. Myotoxicity in vivo and in vitro
We evaluated the in vivo myotoxicity of Bothrops jararacussu
venom by measuring the increase of plasma CK activity induced
by perimuscular injection of venom alone or associated with
Combretum leprosum extract or arjunolic acid. The venom was
dissolved in physiological saline solution (PSS) to a ﬁnal volume of
0.1 mL (1.0 mg/kg) and injected next to the extensor digitorum
longus (EDL) muscles, in order not to cause direct mechanical
damage to the muscle, as previously described (Calil-Elias et al.,
2002b). Negative controls consisted of mice injected with the
same volume of PSS. To evaluate the antimyotoxic activity of
the Combretum leprosum extract (250 mg/kg) and arjunolic acid
(70 mg/kg), three different protocols were used, as follows. Pre-
incubation: venom dissolved in PSS was ﬁrst incubated with the
extract or arjunolic acid for 30 min at room temperature prior to
injection; pretreatment: 0.15 mL of the extract or arjunolic acid
was injected intraperitoneously (i.p.) 15 min before the i.m. venom
injection; post-treatment: 0.15 mL of the extract or arjunolic acid
Fig. 1. The chemical structure of the pentacyclic triterpene arjunolic acid isolated
from Combretum leprosum.
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was injected i.p. 15 min after the i.m. venom injection. Blood was
collected under anesthesia from the orbital plexus with hepar-
inized capillaries, immediately before and two hours after venom
injection, and CK activity in plasma was determined according to
previously described procedures (Melo and Suarez-Kurtz, 1988a,
1988b). Twenty-four hours after venom injection, mice were
sacriﬁced under anesthesia and had their EDL muscles isolated
to measure CK content within the muscles. The doses used here
were based on the dose-response study (not shown), from where
we chose the most effective ones.
In order to assess the loss of creatine kinase from isolated
muscle cells, which indicates damage to the sarcolemma, in vitro
assays were performed as previously described (Melo and Suarez-
Kurtz, 1988b; Melo et al., 1993, 1994). Brieﬂy, mouse extensor
digitorum longus (EDL) muscle was removed, mounted in collect-
ing units and continuously superfused, using a peristaltic pump,
with physiological saline solution (PSS), which was composed of
(mM): NaCl, 135; KCl, 5; CaCl2, 2; MgCl2, 1; NaHPO4, 1; NaHCO3, 15;
and dextrose, 11. The pH of this solution was equilibrated to
7.3 with 5% CO2 / 95% O2. During the superfusion, the muscles
were exposed to Bothrops jararacussu venom (25 μg/mL) or Triton-
X (0.01%), and Combretum leprosum extract (10–100 μg/mL) or
arjunolic acid (10 and 100 μg/mL) that were added to the PSS.
Perfusion samples were collected at 30 min intervals and replaced
with fresh solution. The collected samples were stored at 4 1C and
their CK activity was determined with uv spectrophotometry at
340 nm, according to previously described procedures, consider-
ing the muscles’ masses (Melo and Suarez-Kurtz, 1988a, 1988b).
2.3. Thigh edema
The induction of edema was evaluated by an intramuscular
injection of 50 mL Bothrops jararacussu venom (1 mg/kg). Three
treatment protocols were used: the venom was preincubated at
room temperature with the crude extract (100 mg/kg) or arjunolic
acid (30 mg/kg) for 30 min before the i.m. injection; the extract
(100 mg/kg) or arjunolic acid (30 mg/kg) was orally administered
15 min before the venom injection; and the post-treatment, where
the animals received the extract (100 mg/kg) or arjunolic acid
(30 mg/kg) i.p. injection 5 min after the venom injection. The
doses used here were based on the dose-response study (not
shown), from where we chose the most effective ones. The thigh
area was measured using a caliper rule.
2.4. Hemorrhagic activity
The hemorrhagic effect was induced by an intradermic (i.d.)
injection of 0.1 mL of Bothrops jararaca venom (1 mg/kg) in the
abdomen of mice and quantiﬁed as previously described (Melo
et al., 1994). The negative control received 0.1 mL of PSS i.d.
injection. To evaluate the antihemorrhagic activity of the Combretum
leprosum extract and arjunolic acid, three different protocols were
used: preincubation: Bothrops jararaca venom dissolved in PSS was
ﬁrst incubated with the extract (10 or 100 mg/kg) or arjunolic acid (3
and 30 mg/kg) for 15 min at room temperature prior to injection;
pretreatment: 0.2 mL of arjunolic acid (3 and 30 mg/kg) was
administered orally 30 min before the intradermic (i.d.) venom
injection; post-treatment: 0.15 mL of arjunolic acid (30 mg/mL)
was administered i.p. 5 min after the intradermic (i.d.) venom
injection. Two hours after the venom injection, animals were killed
by ether anesthesia, and the skin covering the abdomen was
removed, stretched, and dried at room temperature for 72 h. The
skin was ﬁxed to a lucite base plate, and the entire area at the
injection site and the surrounding area were transilluminated using
an incandescent light. Light transmitted over an area of 109mm2
was read, and light transmission or the absorbance was normalized
by taking the mean values of the readings over skin injected with
either PSS (calibrated to zero) or Bothrops jararaca venom as
arbitrary units of absorbance (AU). The doses used here were based
on the dose-response study (not shown), from where we chose the
most effective ones.
2.5. Tail bleeding evaluation
Tail bleeding tests were performed in groups of 5 mice each
by a modiﬁed method, as previously described (Broze et al.,
2001). Bothrops jararaca venom was administered (0.1 mg/kg,
i.v.) in anesthetized mice (pentobarbital 40 mg/kg i.m.þxylazine
2.5 mg/kg i.p.). Several minutes later, the mice were immobilized
in a restraint device and had their tails cut 4 mm from the tip and
immersed in tubes with 5.0 mL of normal distilled water at room
temperature. Blood loss was evaluated one hour later as a function
of absorbance at 540 nm due to the hemoglobin content in the
saline solution. The absorbance detected for a group that received
saline rather than venom was taken as a control of blood loss, and
the amount of bleeding in each procedure was expressed as units
of absorbance in 540 nm. For evaluation of the antiophidic activity,
the venomwas preincubated at room temperature with Combretum
leprosum extract (30 mg/kg) or arjunolic acid (1–30 mg/kg) 30 min
before the i.v. injection, and a group of animals received oral pre-
treatment with arjunolic acid (30 mg/kg) 30 min before venom
injection.
2.6. Clotting time
The clotting time was assessed by the modiﬁed Lee–White
method (Raphael, 1983). The animals were grouped (n¼4 for each
group) and about 50 μL of blood were collected from the orbital
plexus using microhematocrit capillary tubes. Before collecting
blood, the tubes were ﬁlled with 20 μL of PSS; Bothrops jararacussu
or Bothrops jararaca crude venoms (1 μg/mL); and venom pre-
incubated for 30 min with Combretum leprosum extract (1 and
10 μg/mL) or arjunolic acid (1 and 10 μg/mL). The clotting time was
evaluated and compared among the different groups.
2.7. Phospholipase activity
Phospholipase A2 activity was assessed by adapting the turbi-
dimetric assay described previously (Marinetti, 1965). We pre-
pared the substrate by shaking one chicken egg yolk in a solution
of 150 mM NaCl to a ﬁnal volume of 100 mL and stored this at 4 1C
prior to the reaction. In each assay, we prepared several tubes by
taking a ﬁnal volume (0.33 mL) of a 10% dilution of the egg yolk
suspension and adding it to a solution containing 150 mM NaCl,
10 mM CaCl2, 0.01% taurocholic acid, and 5.0 mM Tris–HCl (pH
7.4), The tubes were kept at 37 1C during the procedure. The
reactions were started by adding 10 mg/mL of Bothrops jararacussu
or Bothrops jararaca venom or 3 mg/mL bothropstoxin II (BthTx-II, a
phospholipase A2 from Bothrops jararacussu venom) alone or
preincubated for 30 min at 37 1C with Combretum leprosum extract
(10–100 mg/mL) or arjunolic acid (0.1–300 μg/mL). Thirty minutes
after starting the reactions, the absorbance of the solutions was
read at 925 nm, and data expressed as turbidity decrease and
venom activity (%).
2.8. Proteolytic activities
Azocasein and azocoll were used to determine the proteolytic
activities of Bothrops jararaca and Bothrops jararacussu venoms and
to assess the antagonism by Combretum leprosum extract and
arjunolic acid.
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The proteolytic assay was carried out as previously described
(Garcia et al., 1978). Bothrops jararacussu and Bothrops jararaca
venoms (10 mg/mL) were preincubated with Combretum leprosum
extract (0.1–300 mg/mL) or arjunolic acid (1–300 μg/mL) for
30 min at 37 1C. We added the venoms alone or the mixtures in
a solution containing 0.2% azocasein, 20 mM CaCl2, and 0.2 M Tris–
HCl (pH 8.8). The reaction run for 90 min at 37 1C and was stopped
by the addition of 0.4 mL of 15% (vv) trichloracetic acid, and then
centrifuged at 20,000 rpm. We then removed 1.0 mL of the super-
natant and mixed it with 0.5 mL NaOH (2.0 M). This ﬁnal solution
was analyzed by spectrophotometry at an absorbance of 420 nm.
The collagenase activity was assessed by the modiﬁed method
of Chavira et al. (1984). Azocoll (0.2 mL, 0.15%), used as substrate,
was suspended in Tris–HCl buffer solution pH 8.0 (0.2 M, 20 mM
CaCl2) and further added to 0.4 mL of Tris–HCl solution pH 7.5
(5.0 mM). The venoms of Bothrops jararacussu and Bothrops jarar-
aca (50 mg/mL), alone or in the presence of Combretum leprosum
extract (1.0–300 mg/mL) or arjunolic acid (1.0–100 μg/mL), were
dissolved in azocoll solution. The reaction run for 90 min at 37 1C
and was then centrifuged. Then, the supernatant (0.4 mL) was
collected, 0.4 mL of 15% trichloroacetic acid was added to stop the
reaction, and the resulting solution was analyzed by spectro-
photometry at an absorbance of 520 nm.
2.9. Hyaluronidase activity
We used the method described by Di Ferrante (1956), with
minor modiﬁcations, to assess the ability of Bothrops jararacussu
and Bothrops jararaca venoms (50 μg/mL) to degrade hyaluronic
acid. The hyaluronic acid solution (10 μg/mL) was prepared in
acetate buffer solution (0.02 M, pH 6.0). The venoms alone or pre-
incubated with arjunolic acid (0.1–30 μg/mL) for 30 min were
added to the solution, and the tubes were incubated for 15 min
at 37 1C. Hexadecytrimethylammonium bromide (0.666 mL, 2.5%)
was added to the tubes for absorbance readings at 400 nm. Results
are expressed in percentage of venom activity vs. arjunolic acid
concentration.
2.10. Systemic effects (lethality and hematocrit)
In order to evaluate the systemic effect of Bothrops jararacussu
venom and the protection by arjunolic acid, mice (groups of 5)
received intraperitoneal (i.p.) injection of venom (5 mg/kg). The
triterpene was given orally (30 and 100 mg/kg) 30 min before
venom (pre-treatment); together with the venom following
30 min preincubation (100 mg/kg); or 5 min after venom injection
(100 mg/kg, posttreatment). Mice were observed during 72 h to
quantify the number of survivors.
Another set of animals also received intraperitoneal (i.p.)
injection of Bothrops jararacussu venom (5 mg/kg), plus oral pre-
and posttreatment with arjunolic acid (30 mg/kg) 30 min before and
5 min after venom injection, respectively, besides injection together
with the venom following 30 min preincubation (30 mg/kg). In all
groups, the animals were anesthetized under diethyl ether for blood
collection 2 h after venom injections to evaluate the hematocrit. The
blood was collected from the orbital plexus with heparinized
capillaries, centrifuged and analyzed using a percentage hematocrit
ruler.
2.11. Statistical analysis
Data were expressed as mean7SEM, and One-Way Analysis of
Variance (ANOVA) was used to compare groups with one variable,
followed by Dunnett’s post-hoc test. For two variables the Two-
Way Analysis of Variance (ANOVA) was used followed by Bonfer-
roni’s post-hoc test. The p valueo0.05 was used to indicate a
signiﬁcant difference between means. The software GrapPad Prism
version 5.01 was used to provide statistical analysis.
3. Results
3.1. Myotoxic activity
The venom of Bothrops jararacussu showed myotoxic activity, con-
ﬁrming previous observations. Mice isolated EDL muscles exposed to
PSS showed a basal rate of CK release of 0.5270.07 U.g1.h1 that
increased up to 50.3873.47 U g1 h1 when exposed during 90 min
to Bothrops jararacussu crude venom (25 μg/mL, n¼4). Perfusion
in the presence of the crude extract of Combretum leprosum
(10 and 100 μg/mL) reduced the rate of CK release (33.1372.08
and 0.2070.12 U g1 h1, respectively, n¼4) (Fig. 2A). Thereafter,
two groups of EDL muscles were perfused during 120 min. One of the
groups was bathed with venom alone (25 μg/mL) for the ﬁrst 60 min
and thenwith venomþextract (100 μg/mL) for the remaining 60 min,
while another group of muscles received venomþextract until
60 min, when extract was removed. Interestingly, the proﬁle of CK
release changed in the two groups, as we can observe in Fig. 2B.
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Fig. 2. Effect of Combretum leprosum extract and arjunolic acid on Bothrops jararacussu venom myotoxicity in vitro. The panels show the rate of creatine kinase (CK) release
from isolated mouse extensor digitorum longus (EDL) muscles following exposure to Bothrops jararacussu venom (V) alone or incubated with Combretum leprosum extract
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F.F.A. Fernandes et al. / Journal of Ethnopharmacology 155 (2014) 552–562 555
On its turn, arjunolic acid (10 and 100 μg/mL) also reduced the rate of
CK release (38.071.34 and 19.072.64 U g1 h1, respectively)
(Fig. 2C). Finally, we tested the myotoxic activity of the unspeciﬁc
cytotoxic agent Triton-X. When exposed to Triton-X alone (0.01%),
the muscles’ rate of CK release reached 33.7774.76 U g1 h1,
which did not change signiﬁcantly in the presence of Combretum
leprosum extract (28.1974.19 U g1 h1), showing that the extract
does not interfere with the type of cellular injury caused by Triton-X
(data not shown).
Intramuscular injection of Bothrops jararacussu crude venom
(1 mg/kg) caused an increase in plasma CK activity compared to
PSS injection (maximum activities two hours after injection:
2170.417287.35 U/L vs. 62.9675.07 U/L respectively, n¼5).
Neither the pre- nor the posttreatment with Combretum leprosum
extract (250 mg/kg) were able to alter the venommyotoxic activity
(1933.277316.01 and 2156.487187.40 respectively), while pre-
incubation of the venom with the same dose of Combretum
leprosum extract signiﬁcantly inhibited the venom activity
(285.36778.95 U/L; Fig. 3A). On the other hand, when we tested
arjunolic acid instead of crude extract we also observed preincu-
bation inhibiting Bothrops jararacussu myotoxicity, but here the
pre-treatment also showed some inhibition (Fig. 3B). Arjunolic
acid was also effective in preserving CK content within EDL muscle
24 h after perimuscular venom injection comparing to PSS injec-
tion (venom: 516.98746.00 and PSS: 819.58735.76 U/g), espe-
cially in pre-incubation protocol (770.00747.00 U/g) (Fig. 3C).
3.2. Edematogenic activity
Bothrops jararacussu venom i.m. injection (1.0 mg/kg) led to
edema formation in mice hind limb, which was measured during
90 min with a peak of edema in around 15 min (Fig. 4A and C).
Fig. 4B and D shows the area under the curve calculated from Fig. 4A
and C. We can seen in Fig. 4B that the venom increased the AUC in
about 42% compared to PSS injection. Combretum leprosum extract,
both in preincubation and pretreatment, but not in posttreatment,
decreased the edema formation. Similarly, arjunolic acid preincu-
bated with the venom abolished edema formation, while pre- and
posttreatment have been partially effective (Fig. 4D).
The loss of ﬂuid to the third space, i.e. to the interstitium, leading
to edema formation, was also observed indirectly by measuring the
hematocrit. Hemoconcentration caused by of Bothrops jararacussu
venomwas conﬁrmed two hours after intraperitoneal injection (data
not shown), when hematocrit levels reached 55.270.9%, while
animals receiving PSS presented 48.871.5%. Preincubation with
arjunolic acid 30 mg/kg maintained the hematocrit levels similar to
PSS (48.970.8%), while pre-treatment showed partial effect
(51.070.4%) and posttreatment had no effect.
3.3. Effect of Combretum leprosum extract and arjunolic acid
on hemostasis
The intradermic injection of Bothrops jararaca crude venom
(1 mg/kg) induced intense hemorrhage on mouse abdomen skin
when compared to animals receiving only PSS injection (from
226.62756.23 to 591.12760.00 arbitrary units), and was used as
100% of hemorrhagic activity. When the venom was preincubated
with 100 mg/kg Combretum leprosum extract the hemorrhagic
activity was completely inhibited. Posttreatment of the animals
with arjunolic acid did not prevent the skin hemorrhage (not
shown), but the preincubation and the pretreatment with 30 mg/kg
of arjunolic acid reduced the venom hemorrhagic activity down to
about 12% and 58%, respectively (Fig. 5A).
Bothrops jararaca venom (0.1 mg/kg) was able to induce an
increase in the bleeding amount from mice tails, from 410.607
33.35 (PSS control) up to 831.40783.44 absorbance units at 540 nm
(Fig. 5B). The preincubation of the venom with both the extract and
arjunolic acid (30 mg/kg) reduced the bleeding amount down to
657.00738.00 and 407.00740.00 absorbance units, respectively,
but the oral pretreatment was not effective (not shown).
The clotting time when microhematocrit capillary tubes were
preﬁlled with PSS was 157.44711.32 s (Fig. 5C). Bothrops jararaca
venom induced a procoagulant activity, reducing the clotting time of
mouse blood down to 18.1472.47 s. Combretum leprosum extract at
10 μg/μL completely inhibited the procoagulant activity induced by
Bothrops jararaca venom (181.25737.78 s). Arjunolic acid (10 μg/mL)
also inhibited Bothrops jararaca activity (140.00710.00 s), and inter-
estingly the concentration of 30 μg/mL prevented blood coagulation
for more than 10 min (741.60740.98 s, data not shown). Bothrops
jararacussu venom also presented procoagulant activity, with the
same proﬁle of inhibition by Combretum leprosum extract.
3.4. Enzymatic activities
3.4.1. Phospholipase activity
The phospholipases present in the venoms of snakes Bothrops
jararacussu and Bothrops jararaca, when placed in contact with
a phospholipid substrate, such as lecithin (phosphatidylcholine),
decreased the turbidity of the egg yolk solution used in the experi-
mental protocol. The venoms and BthTx-II caused a concentration-
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and time-dependent decrease in turbidity (not shown for BthTx-II),
and such activities were considered 100% phospholipase activities.
Fig. 6A and B shows the inhibition of phospholipase activities of
10 μg/mL Bothrops jararacussu and Bothrops jararaca venoms, respec-
tively, by Combretum leprosum extract (10–100 μg/mL). On its turn,
arjunolic acid also reduced the phospholipase activities of the venoms
(6C) and BthTx-II (6D) in a concentration-dependent way. Phospho-
lipase activities were decreased down to approximately 45% and 25%
when 300 μg/mL arjunolic acid was incubated with Bothrops
jararacussu and Bothrops jararaca venoms, respectively, and to 30%
when 30 μg/mL of the triterpene was incubated with BthTx-II.
3.4.2. Proteolytic activity
Bothrops jararacussu and Bothrops jararaca venoms induced
hydrolysis of azocasein in a concentration-dependent way (not
shown). Combretum leprosum extract (0.1–300 μg/mL) decreased,
also in a concentration-dependent way, the proteolytic activities of
the venoms (10 μg/mL), and the concentration of 300 μg/mL
reduced the venoms’ proteolytic activities down to zero (Fig. 7A).
Arjunolic acid (1–300 μg/mL) also inhibited the hydrolysis of
azocasein by the venoms. Inhibition was about 55% and 60% when
300 μg/mL arjunolic acid was incubated with Bothrops jararacussu
and Bothrops jararaca venoms, respectively (Fig. 7B).
3.4.3. Collagenase activity
Bothrops jararacussu and Bothrops jararaca venoms induced the
release of the Azo group from the substrate (Azocolls), increasing
the absorbance in a concentration-dependent way (data not
shown). The incubation of 50 mg/mL of the venoms with Combretum
leprosum extract (1–300 μg/mL, Fig. 7C) and arjunolic acid (0.1–
100 μg/mL, Fig. 7D) antagonized their collagenase activity in a
concentration-dependent way. Combretum leprosum extract (300
μg/mL) reduced the Bothrops jararaca and Bothrops jararacussu
collagenase activities down to approximately 2579% and 271%,
respectively, while arjunolic acid (100 μg/mL) reduced their activ-
ities down to 4479% and to 3977%, respectively.
3.4.4. Hyaluronidase activity
Bothrops jararacussu and Bothrops jararaca venoms degraded
hyaluronic acid in a concentration-dependent way (not shown).
Arjunolic acid (0.1–30.0 μg/mL) inhibited the enzymatic activity of
both venoms. This inhibition was of approximately 65% and 76%
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when 30 μg/mL arjunolic acid was incubated with Bothrops
jararacussu and Bothrops jararaca, respectively (Fig. 8).
3.5. Inhibition of lethality
Finally, after observing the effects of the venoms on both
enzymatic and cellular/tissue levels, we assessed the lethality of
Bothrops jararacussu venom and its inhibition by arjunolic acid.
Intraperitoneal injection of Bothrops jararacussu venom induced
the death of all the animals in up to 48 h. Oral pre-treatment with
30 and 100 mg/kg arjunolic acid reduced the lethality in more
than 65% and 80%, respectively, while preincubation with the
triterpene (100 mg/kg) prevented the death of all the animals.
Posttreatment, on the other hand, did not prevent the animals’
death (data not shown).
4. Discussion
Our results have shown that Combretum leprosum extract could
inhibit some important toxic activities of the venoms of the snakes
Bothrops jararacussu and Bothrops jararaca, both in vitro and
in vivo. We observed a concentration-dependent protection of
the mouse EDL muscle by the extract, in vitro, from the myotoxic
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effect of Bothrops jararacussu venom. This protective effect was
also observed in the experiments in vivo under different protocols.
The cytotoxic effect induced by Bothrops venoms is attributed to
the presence of complex toxins, which have been targeted by
several pharmacological studies showing different degrees of
inhibition by different natural and synthetic substances (Melo
et al., 1993, 1994; Arruda et al., 2002; Calil-Elias et al., 2002a,
2002b; Sifuentes et al., 2008; Patrão-Neto et al., 2013; Strauch
et al., 2013).
In agreement with the present results, the work of de Morais
Lima et al. (2012) has shown that some Combretum species are
extensively used in traditional medicine against inﬂammation,
infections, diabetes, malaria, bleeding, diarrhea and digestive
disorders and others as a diuretic. Some studies involving the
investigation of biological activities of Combretum leprosum point
to similar actions as those observed for other species of the genus.
Facundo et al. (2005) demonstrated that oral administration of
both the root extract of Combretum leprosum and arjunolic acid
presented anti-inﬂammatory activity reducing the paw edema
induced by carrageenan. Oral arjunolic acid was still capable of
reducing ear edema induced by topical application of arachdonic
acid (AA), but did not alter the ear edema formed by applying
topical 12-O-tetradecanoylphorbol-13-acetate (TPA), suggesting
that the compound would be acting to inﬂuence the route of
metabolism of AA by action of the enzyme cyclooxygenase (COX).
Also in this study it was found that the extract of the roots of
Combretum leprosum was able to inhibit the activity of enzymes
butyryl and acetylcholinesterase by action of arjunolic acid.
Longhi-Balbinot et al. (2012) and Lopes et al. (2012) demonstrated
the antinociceptive activities of 3β, 6β, 16β-trihydroxylup-20(29)-
ene (TTHL) and epicatechin, respectively, compounds isolated
from extracts of Combretum leprosum, which may involve the
participation of complex enzymatic systems. Recently, Horinouchi
et al. (2013) have also demonstrated antiproliferative and anti-
inﬂammatory properties of ﬂower extract of Combretum leprosum
in models of skin inﬂammatory and hyperproliferative process.
On the other hand, the myotoxic effect of Bothrops jararacussu
venom has been ascribed to the action of its components with
proteolytic and phospholipase A2 activities, as well as to some
basic polypeptides that can act directly disrupting the sarcolemma
(Queiroz et al., 1984; Homsi-Brandeburgo et al., 1988; Calil-Elias
et al., 2002a, 2002b; Gutiérrez and Ownby, 2003; Murakami et al.,
2005). Additionally, recent data have shown a strong contribution
of inﬂammation in the process of myonecrosis induced by Bothrops
venoms (Patrão-Neto et al., 2013). One interesting point has been
observed in the experiments carried out with isolated EDL muscle
when we added Combretum leprosum to the bath solution contain-
ing Bothrops jararacussu venom. Initially, the high rate of CK
release caused by the venom was decreased by the extract, but
when we washed the extract out from the solution, exposing the
muscle only to the venom, the rate of CK release increased again.
This protocol showed that the inhibition was readily reversible,
suggesting that the extract and venom must interact for the
antagonism to occur.
The in vivo protocols showed that the pre-incubation of
Bothrops jararacussu venom and Combretum leprosum extract
prevented the increase of plasma CK activity more effectively than
the post- and pretreatment protocols. In this last, we tried to
reproduce a frequent situation, described in folk medicine, when
people take antiophidic plant preparations before any possible
contact with snakes (Mors et al., 1989, 2000a; Strauch et al., 2013).
Similarly to the speciﬁc antivenom, our pretreatment protocols
with Combretum leprosum extract suggest that protection of the
sarcolemma from the venom depends, at least in part, on
the direct interaction of venom components with Combretum
leprosum compounds. These data are in agreement with previous
studies showing the same grade of venom neutralization by the
antibothropic polyvalent antivenom, by using E. prostrata crude
extract or its isolated component wedelolactone, as well as some
polyanions as antimyotoxic agents (Melo and Suarez-Kurtz, 1988a,
1988b; Melo et al., 1993, 1994; Arruda et al., 2002; Da Silva et al.,
2007). This antimyotoxic effect of Combretum leprosum extract can
be attributed to the inhibition of active enzyme components from
the venom by the extracted compounds, as suggested for other
active antiophidic agents (Melo et al., 1994; Melo and Ownby,
1999). This hypothesis can be supported by the studies of Facundo
et al. (1993, 2005) that have described the presence of different
compounds such as triterpenes and ﬂavonoids in Combretum
leprosum, which may be involved in many biological activities.
One of these triterpenes is arjunolic acid, which is an active
compound found in different Combretum species (Bisoli et al.,
2008; Masoko et al., 2008). In our study, arjunolic acid antag-
onized the myotoxicity of Bothrops jararacussu venom both in vivo
and in vitro, suggesting that this isolated compound is able to
partially reproduce the crude extract activity. It may, thus, repre-
sent the mechanism involved in the antivenom activity.
The acute edema induced by Bothrops jararacussu venom was
inhibited by Combretum leprosum extract and arjunolic acid in
different protocols. The edema induced by viperid venoms may be
explained by the transitory inﬂammatory process initiated by
cytotoxic venom components and mediators such as autacoids,
cyclic endoperoxide, serotonin, histamine, and agents that are not
directly inhibited by the polyvalent antivenom (Rojas et al., 2005;
Patrão-Neto et al., 2013). The edema antagonism could be the
result of the inhibition of such enzymatic venom components. For
example, both the extract and arjunolic acid showed the ability to
inhibit Bothrops jararacussu venom PLA2 activity, and this action
could be related to the reduction of the edema, similarly to other
substances that inhibited PLA2 activity and the inﬂammatory
edema induced by bothropic venoms (Landucci et al., 2000;
Marcussi et al., 2007; Santos-Filho et al., 2008; Patrão-Neto
et al., 2013). The increased vascular permeability, leading to loss
of ﬂuid to the extracellular space (edema), also causes hemocon-
centration, as shown by the increased hematocrit values in
animals receiving venom injection. Our results indicate hemocon-
centration two hours after venom injection, but we believe that
the hematocrit values could have been higher before the point of
blood collection, probably accompanying the edematogenic activ-
ity of the venom. As well as edema inhibition, arjunolic acid also
signiﬁcantly decreased hemoconcentration.
Our experiments have demonstrated a signiﬁcant antagonism
by the crude extract and by arjunolic acid on the hemostatic
disturbances induced by Bothrops jararaca or Bothrops jararacussu
venoms. Both bleeding amount in vivo and the clotting time
in vitro were antagonized by the crude extract or by arjunolic acid
in a dose- or concentration-dependent manner, respectively.
A dose-dependent antagonism was observed in the subcutaneous
hemorrhage induced by Bothrops jararaca crude venom in the pre-
incubation protocol. Bothrops jararaca venom has several metallo-
proteases and coagulation-disturbing proteins that induce local
hemorrhage and systemic coagulopathies. The hemorrhagic activ-
ity results from the angiorrhexis induced by metalloproteases or
collagenase from the venom, which change the constitution of
the vascular wall and basal lamina (Kamiguti et al., 1986, 1991;
Baramova et al., 1990; Paine et al., 1992; Bjarnason and Fox, 1994;
Fujimura et al., 1995). Previous studies have reported that these
hemorrhagic proteases are members of the reprolysin family of
zinc metalloprotease, induce rapid degradation of sub-endothelial
matrix proteins and disruption of the blood vessel, and are
involved in local lesions and systemic hemorrhage (Paine et al.,
1992; Kawano et al., 2002; Laing and Moura-da-Silva, 2005;
Gutiérrez et al., 2005). The Combretum leprosum crude extract
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inhibited not only the hemorrhagic activity, but also the pro-
clotting activity of Bothrops jararaca and Bothrops jararacussu
venoms. These venoms induce a decrease in clotting time that
may be directly related to the proteolytic or thrombin-like activ-
ities. Previous studies have shown that some venom metallopro-
teases are “thrombin-like” enzymes that degrade coagulation
factors and, moreover, interact with the basal membrane and
vascular wall, inducing angiorrhexis and hemorrhage (Mebs and
Ownby, 1990; Bjarnason and Fox, 1994; Gutiérrez and Rucavado,
2000). The antagonism of Bothrops jararacussu and Bothrops
jararaca pro-clotting activities in vitro may be directly related
to the inhibition of “thrombin-like” enzymes from the venom that
produce high levels of ﬁbrin, inducing ﬁbrinogen depletion and
leading to the hemorrhagic process. In agreement with this
hypothesis are the results obtained with the inhibition of different
proteolytic enzymes such as caseinolytic enzyme from Bothrops
jararacussu venom, collagenase from bacteria, and Bothrops venom
collagenase activities. It is possible that compounds in the
Combretum leprosum extract inhibit the different enzyme activities
and/or the pharmacological sites of action of these toxins (Melo
and Ownby, 1999; Murakami et al., 2005). However, the mechan-
isms of inhibition, caused by the extract and arjunolic acid, still
need additional study.
Taken together, our results have shown that Bothrops jarara-
cussu and Bothrops jararaca venoms presented myotoxic, edema-
togenic, hemorrhagic, pro-coagulant and diverse enzymatic
activities. All these actions, which are characteristics of many
viperid venoms, including those of Bothrops snakes, may contri-
bute differently for the lethality observed by the intraperitoneal
injection of Bothrops jararacussu venom, which is assumed to be a
consequence of either primary cardiovascular collapse or the
collapse secondary to systemic hemorrhage, plasma extravasation
and hemoconcentration (increased cardiac workload) (Sifuentes
et al., 2008; Gutiérrez et al., 2009, 2013b). In our experiments, the
preincubation of arjunolic acid with Bothrops jararacussu venom
prevented the death of all animals, while oral pretreatment
decreased the lethality in more than 80%. Altogether, the neutra-
lization of Bothrops jararacussu venom lethality by arjunolic acid
could be seen as the sum of the inhibition of each toxic activity.
However, despite the fact that the lethality potency assay is
well established as the gold standard in assessing the preclinical
efﬁcacy of potential antiophidic substances (Gutiérrez et al.,
2013b), it is the neutralization itself of the most relevant toxic
activities induced by medical-relevant snakes, especially Bothrops
snakes in Brazil, that must be emphasized, due to the complexity
of the venoms, the pathophysiology of envenoming and the
clinical and social consequences of snakebites.
5. Conclusion
Overall, the present results, for the ﬁrst time, give scientiﬁc
support for the popular use of Combretum leprosum extract in the
treatment of snakebites in Northeast Brazil. Our data highlight an
important component of crude extract of Combretum leprosum,
arjunolic acid, which can be promising as an antiophidic sub-
stance, once it was able to neutralize critical points in the tissue
damage process induced by the properties of Bothrops jararacussu
and Bothrops jararaca venom hereby investigated.
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